English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 11 June 2021, 10:24 JST
Share:
    

Source: NEC Corporation
Northgate Public Services to improve patient experience and outcomes with acquisition of Vantage Health

TOKYO & LONDON, June 11, 2021 - (JCN Newswire) - NEC Corporation (TSE: 6701) announced that Northgate Public Services (NPS), a wholly owned subsidiary of NEC, has acquired Vantage Health, which provides `Rego', an advanced digital solution to help healthcare providers reduce patient waiting times and cope with increased demand.

Rego reviews all referrals against local criteria and pathways and ensures patients are directed to the right care, the first time. Widely implemented across the U.K.'s National Health Service (NHS) to support thousands of general practitioners, dentists and opticians, Rego is proven to support effective outpatient transformation in line with the NHS' Long Term Plan and helping the organization as it looks towards recovery from the pandemic.

Tina Whitley, CEO of NPS, says: "Following the pandemic, healthcare is facing a huge challenge to keep up with the surge in demand for outpatient treatment. Effective solutions are needed to be able to manage resources, save money and secure the best outcomes for patients.

"Combining Vantage Health's ability to transform outpatient care with our expertise of managing successful health screening programmes like hearing and diabetic eye screening, means we can give healthcare providers the tools they need to quickly identify patients who need specialist services and then help them direct the patient to the right support service instantly."

David Ezra, co-founder of Vantage Health, says: "It's never been more important for the NHS and healthcare services to have efficient solutions that work. Joining forces with NPS is exciting. It brings together a shared vision for transforming the way healthcare is delivered to offer the best care for patients."

NPS already has a significant presence in this sector, following its acquisition of three EMIS Group plc businesses in 2019. This latest move further strengthens its growing preventative health offering.

NPS has helped to screen 10 million babies for the Newborn Hearing Screening Program in England and Northern Ireland, tested 500,000 patients with diabetes for retina damage and supports a number of medical registries such as the National Joint Registry (NJR), the largest orthopaedics registry in the world, and the international spinal registry platform, Spine Tango to help clinicians, regulators and industry deliver evidence-based treatments for patients.

Northgate Public Services (NPS) will become NEC Software Solutions UK from July 2021. The new name brings NPS under the global NEC brand, strengthening the company's position as a market leader in the development of cutting-edge software and services for the local government, police, health and housing sectors.

Topic: Press release summary
Source: NEC Corporation

Sectors: Cloud & Enterprise, MedTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2022 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 
NEC Corporation Links

http://www.nec.com

https://www.facebook.com/nec.global/

https://twitter.com/NEC_corp

https://www.youtube.com/user/NECglobalOfficial

https://www.linkedin.com/company/nec/

NEC Corporation Releated News
2022年8月9日 10時30分 JST
積水ハウスとNEC、集合住宅における顔認証システムを活用した取り組みにおいて連携
2022年8月5日 11時00分 JST
NEC、企業と社会のサステナブルな成長を支えるESGの取り組みを公開
2022年8月3日 12時00分 JST
NECファシリティーズ、大規模地震発生時に事業活動の早期復旧を支援する建物被害状況緊急診断サービスなどを提供開始
2022年8月2日 12時00分 JST
NECとカゴメ、AIで子どもの苦手な野菜と相性の良い食材を導き出した「AI(愛)のプリン」(6種)を開発
Monday, 1 August 2022, 13:13 JST
NEC Visionary Week 2022 to provide insights on the future of society and business
More news >>
Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575